Vacc-iNTS consortium is composed by 12 partners and brings together academic and industry research teams from 4 European countries (Belgium, Italy, Switzerland and United Kingdom), 4 disease endemic countries (Burkina Faso, Ghana, Kenya and Malawi) and 1 non-EU country (New Zealand). The consortium is characterized by a renowned international expertness on vaccine development and characterization, and poverty-related diseases of developing countries.
The Vacc-iNTS project is coordinated by the Sclavo Vaccines Association (www.sclavo.org), a non-profit organization devoted to support research and development of human vaccines.
Linked Third Parties
|Fondazione Achille Sclavo ONLUS||Italy|
|Glaxosmithkline Biologicals SA||Belgium|
|University of Malawi||United Kingdom|